Additional OMS-associated antibodies reported in the literature include anti-Hu/antineuronal nuclear antigen type 1 (ANNA-1), anti Yo/PCA1, anti-Ma2, and anti-NMDAR [42]. The gene discussed is CDR2; the disease is opsoclonus-myoclonus syndrome.